There has been a lot of buzz recently regarding Medtronic’s new 640G insulin pump. Released to the public in Australia this week, it is the first insulin pump to suspend insulin delivery when it predicts there will be a low blood sugar event (this differs from the 530G model which suspends when a low blood sugar level is reached.)
But a lot of news outlets have been touting it as an “artificial pancreas.” But is it really?
photograbetic 